Bendich, Johnson receive ‘CRN Apple’ for nutrition trailblazing
WASHINGTON The Council for Responsible Nutrition on Monday announced that GlaxoSmithKline’s Adrianne Bendich and Byron Johnson of Amway/Nutrilite were awarded the “CRN (Steuben) Apple” at CRN’s annual symposium this weekend.
Bendich is the clinical director, medical affairs at Glaxo and is a recognized authority in women’s health issues involving nutrition. Bendich has been the point person for the GSK research team that provided calcium and vitamin D to the Women’s Health Initiative. In addition to serving on the editorial board of The Journal of Nutrition, the Journal of Women’s Health and the Journal of Nutrition and Immunology, Bendich is the only person to serve continuously as a dietary supplement industry reviewer for the National Institute of Health’s Office of Dietary Supplements annual bibliography since its inception. Bendich has authored more than 150 scientific articles in peer reviewed journals, and has edited over a dozen books for nutrition professionals.
Johnson is the nutrition regulatory policy director for Amway/Nutrilite, where he first began his career more than 25 years ago. Previously, he has served as the nutrition and wellness industry relations director for the company, as well as vice president and general counsel. In his current position, Johnson is responsible for regulatory and corporate compliance matters, as well as trade association participation pertaining to food and dietary supplement policy. Earlier this year, Johnson was elected the chairman of the International Alliance of Food/Dietary Supplement Associations, where he has been an active participant in the organization’s regulatory, scientific and advocacy affairs since its inception in 1998. Johnson served as the chairman of CRN from 2003-2004, and currently remains an active member on the CRN board.
The award, considered CRN’s highest honor, is given to individuals who have demonstrated long-term commitment and outstanding service to CRN and the dietary supplement industry.